TBX1 and neoplasm: Histopathological analysis revealed significantly increased α-SMA+ CAFs infiltration and Lyve-1+ lymphatic vessel density in primary tumors (pT) from H358-CAFs co-injected xenografts compared to H358-only controls (Figure 3c), confirming the establishment of robust CAFs-rich, lymphangiogenic tumor models.